American Society for Clinical Oncology 2025 Annual Meeting May 30 – June 3 (Exhibits May 30 – June 2) | McCormick Place, Chicago IL Meet QuartzBio’s team of experts at this year’s annual ASCO meeting! See firsthand how AI agents designed for cancer research can accelerate oncology R&D and help teams like yours: Our team […]
Learn how to use practical, conversational AI to amplify the power of your biomarker-rich clinical programs with QuartzBio’s Biomarker Intelligence Platform. You’ll discover QuartzBio’s approach, which employs smart, automated integration of biomarker, sample, and clinical data to create a unified data ecosystem — now amplified with the power of conversational interactions to enable more consumable insights.
Precision for Medicine is the first biomarker-driven clinical development organization supporting life sciences companies in the use of biomarkers essential to targeting patient treatments. Precision for Medicine is part of Precision Medicine Group, with 3,000 employees in 40 locations.
QUARTZBIO® and the PRECISION QUARTZBIO® logo are registered trademarks of Precision Medicine Group, LLC in the United States and/or other jurisdictions. All rights reserved.
© 2024. All rights reserved.
Precision Medicine Group, LLC.
Privacy Policy | GDPR
Web Design and Development by RainCastle Communications.